Inhibition of RIPK1-MLKL axis can increase hepatocellular mitochondrial respiratory, followed by decreased hepatocellular triglycerides, thus reversing the progression of NAFLD [162]. This evidence concerns the gene RIPK1 and metabolic dysfunction-associated steatotic liver disease.